Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).

QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in ...

A drug called riluzole, commonly used to treat amyotrophic lateral sclerosis (ALS) and other motor neuron diseases, could also assist in recovery from spinal cord injuries, according to research from ...

New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI computational models that predict ...

One of the brain’s fundamental roles is to generate the correct body movements at the correct time. Understanding how the brain accomplishes this task, and how this process goes wrong in disease, has ...

ALS, also known as Lou Gehrig's disease, is among the most challenging neurological disorders: relentlessly progressive, universally fatal, and without a cure even after more than a century and a half ...

Footballer Ezekiel Otuoma and his wife Rachael Otuoma. Otuoma died after a long battle with Motor Neurone Disease (MND). [File, Standard] Former AFC Leopards winger Ezekiel Otuoma passed away at the ...

Researchers have used a new technique to identify pathological abnormalities associated with motor neurone disease. Pathological abnormalities associated with motor neurone disease have been ...

A new medicine, discovered by scientists, protects nerve cells damaged by motor neurone disease (MND), offering hope of substantially slowing the progression of "one of the cruellest diseases".